Actively Recruiting
Low-frequency Repetitive Transcranial Magnetic Stimulation to Reduce Visceral Pain in Irritable Bowel Syndrome With Diarrhea Using Medial Prefrontal Cortex Targeting
Led by The First Affiliated Hospital of Soochow University · Updated on 2025-11-21
42
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying irritable bowel syndrome with diarrhea (IBS-D), focusing on chronic visceral pain and how brain activity contributes to this pain. The trial aims to identify key brain regions responsible for visceral pain and to understand how repetitive transcranial magnetic stimulation (rTMS) to the medial prefrontal cortex (mPFC) might reduce this pain. Forty-two IBS-D patients participated, with some undergoing brain imaging before treatment to support the research. Participants were randomly assigned to two groups: one receiving low-frequency rTMS applied to the mPFC daily for 20 minutes over two weeks, and the other receiving sham stimulation where the coil was placed similarly but without active magnetic pulses, accompanied by prerecorded sounds to mimic treatment. Both groups completed the two-week intervention with treatments delivered under blinded conditions to prevent bias. Throughout the study, participants underwent assessments including the Visceral Sensitivity Index and the IBS symptom severity score to measure changes in visceral pain and symptom severity. Brain imaging and other evaluations were performed as part of the nested cohort. Safety and treatment effects were monitored over the two-week period, with all participants included in the final analysis to determine the impact of rTMS on IBS-D symptoms.
CONDITIONS
Brief Title
Lf-rTMS Attenuates Visceral Pain in Irritable Bowel Syndrome With Diarrhea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years
- Diagnosis of irritable bowel syndrome with diarrhea (IBS-D) according to Rome IV criteria
- Diagnosis confirmed by a board-certified gastroenterologist
You will not qualify if you...
- Presence of inflammatory or other organic gastrointestinal diseases
- Diagnosed psychiatric disorders
- History of anorectal, intestinal, or abdominal surgery
- Pregnancy or lactation
- Presence of metallic implants or cardiac pacemakers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 weeks
Participants receive low-frequency repetitive transcranial magnetic stimulation (rTMS) or sham stimulation targeting the medial prefrontal cortex.
Daily visits for 20 minutes each
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China, 215006
Actively Recruiting
Research Team
R
Ruixia Weng, Dr.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here